(Q40224511)

18 September 2017

title

Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo (English)

1 reference

18 September 2017

1 reference

Guang-Biao Zhou

1

1 reference

18 September 2017

Sai-Juan Chen

series ordinal

2

1 reference

18 September 2017

Zhen-Yi Wang

series ordinal

3

1 reference

18 September 2017

Zhu Chen

series ordinal

4

1 reference

18 September 2017

language of work or name

1 reference

1 April 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

17

1 reference

18 September 2017

issue

4

1 reference

18 September 2017

page(s)

274-276

1 reference

https://api.crossref.org/works/10.1038%2FCR.2007.21

18 September 2017

1 reference

7 January 2021

Cytotoxic and antitumor activities of Rabdosia diterpenoids

1 reference

https://api.crossref.org/works/10.1038%2FCR.2007.21

7 January 2021

Antitumor activity of the isodon diterpenoids: Structural requirements for the activity

1 reference

https://api.crossref.org/works/10.1038%2FCR.2007.21

7 January 2021

Acute promyelocytic leukemia: a model of molecular target based therapy.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2007.21

7 January 2021

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2007.21

7 January 2021

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCR.2007.21

7 January 2021

Identifiers

DOI

10.1038/CR.2007.21

1 reference

Dimensions Publication ID

18 September 2017

1023459153

0 references

1 reference